GlassScriptPhysician profile
Michael Savisky
NPI 1841819463
$16,371.81
in general payments reported to CMS, 2019-2025
13 companies · $2,041 in 2025
The $2,041 reported for 2025 was more than what 84% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.26 · 2020: $240 · 2021: $3,025 · 2022: $4,114 · 2023: $2,161 · 2024: $4,776 · 2025: $2,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,391 · Food and Beverage: $3,587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,390.51 |
| Food and Beverage | $3,587.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $7,252.05 | 2021-2025 | |
| Stryker Corporation | $5,665.01 | 2021-2025 | Inbone, Infinity, Prostep |
| Arthrex, INC. | $1,101.70 | 2024-2025 | |
| Exactech, INC. | $999.21 | 2023-2025 | |
| Kerecis Limited | $352.79 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $347.00 | 2021-2022 | |
| Polynovo North America LLC | $209.88 | 2022-2025 | Novosorb Btm |
| Smith+Nephew, INC. | $131.69 | 2020-2023 | Cadence |
| Zimmer Biomet Holdings, INC. | $127.15 | 2020 | |
| Trice Medical, INC. | $125.96 | 2021 | |
| Dunamis Medical, LLC | $25.38 | 2024 | |
| Bioventus LLC | $18.73 | 2025 | Exogen Ultrasound Bone Healing System |
| Bsn Medical INC | $15.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Savisky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.